Financhill
Buy
57

MMSI Quote, Financials, Valuation and Earnings

Last price:
$100.39
Seasonality move :
10.04%
Day range:
$98.89 - $101.15
52-week range:
$70.70 - $111.45
Dividend yield:
0%
P/E ratio:
49.24x
P/S ratio:
4.37x
P/B ratio:
4.26x
Volume:
490.1K
Avg. volume:
624.1K
1-year change:
38.43%
Market cap:
$5.9B
Revenue:
$1.4B
EPS (TTM):
$2.03

MMSI Analysts' Consensus Rating

The 6 analysts providing 12-month price projections for Merit Medical Systems shares anticipate an average target of $118.20, ranging from a low estimate of $111.00 to a high estimate of $128.00. This average target implies a growth of 18.26% compared to the current stock price of $99.95.

Consensus Price Target

$118.20

Highest Price Target

$128.00

Lowest Price Target

$111.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 4 5 5

Hold 2 1 1

Sell 0 0 0
Consensus Buy Buy Buy

MMSI Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Alphabet Stock No Longer a Good Bet?
Is Alphabet Stock No Longer a Good Bet?

Alphabet tripled its price per share over the past 5…

Pepsi Vs Coke Stock: Which Is Best?
Pepsi Vs Coke Stock: Which Is Best?

Coca-Cola (NYSE:KO) and PepsiCo (NYSE:PEP) are two of the largest…

Is CyberArk The Next Big Cybersecurity Stock?
Is CyberArk The Next Big Cybersecurity Stock?

CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Sell
48
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Sell
49
SRPT alert for Mar 19

Sarepta Therapeutics [SRPT] is up 8.8% over the past day.

Sell
46
CVNA alert for Mar 19

Carvana [CVNA] is up 4.99% over the past day.

Buy
93
ESLT alert for Mar 19

Elbit Systems [ESLT] is up 0.6% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock